The Investor Relations website contains information about Collegium Pharmaceutical Inc.'s business for stockholders, potential investors, and financial ...
The bid & ask refers to the price that an investor is willing to buy or sell a stock. ... Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
Christopher Shayne James M.D., Vice President of Investor Relations, --, --, --. Mr. Bart J. Dunn, Executive Vice President of Strategy & Corporate Development ...
People also ask
When was Collegium Pharmaceuticals founded?
What does Collegium Pharmaceutical do?
How do I contact Collegium Pharmaceuticals?
COLL 8.3 Investor relations · Application · Drawing up and availability of a prospectus · False or misleading prospectus · Table: contents of qualified investor ...
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
Feb 22, 2024 · (NASDAQ:COLL) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET. Company Participants. Christopher James - VP of Investor Relations
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
Missing: relations | Show results with:relations